We are live on ! Find out more
PALI icon

Palisade Bio
PALI

5 hedge funds and large institutions have $5.14M invested in Palisade Bio in 2017 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

16% more call options, than puts

Call options by funds: $2.9M | Put options by funds: $2.5M

0% less ownership

Funds ownership: 0% → 0% (-0%)

29% less funds holding

Funds holding: 7 → 5 (-2)

35% less capital invested

Capital invested by funds: $7.85M → $5.14M (-$2.71M)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

Holders
5
Holders Change
-2
Holders Change %
-28.57%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
3
Calls
$2.9M
Puts
$2.5M
Net Calls
+$397K
Net Calls Change
-$75K

Top Buyers

Rank Fund Capital Flow
1
William Blair & Company
William Blair & Company
Illinois
+$439K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$2.63M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$439K
3
VKH
Virtu KCG Holdings
New York
-$439K
4
Millennium Management
Millennium Management
New York
-$62K
5
PNC Financial Services Group
PNC Financial Services Group
Pennsylvania
-$28K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$2M – – –
ACM
2
Alethea Capital Management
Washington
$952K – – –
BlackRock
3
BlackRock
New York
$545K – – –
William Blair & Company
4
William Blair & Company
Illinois
$506K +$439K +1 New
Geode Capital Management
5
Geode Capital Management
Massachusetts
$481K – – –
BRWA
6
B. Riley Wealth Advisors
Florida
$134K – – –
Northern Trust
7
Northern Trust
Illinois
$116K – – –
Commonwealth Equity Services
8
Commonwealth Equity Services
Massachusetts
$89K – – –
VKH
9
Virtu KCG Holdings
New York
$81K -$439K -1 Closed
California Public Employees Retirement System
10
California Public Employees Retirement System
California
$69K – – –
Fifth Third Bancorp
11
Fifth Third Bancorp
Ohio
$53K – – –
Wells Fargo
12
Wells Fargo
California
$33K – – –
Morgan Stanley
13
Morgan Stanley
New York
$18K – – –
LTFS
14
Ladenburg Thalmann Financial Services
Florida
$16K – – –
FO
15
FT Options
Illinois
$15K – – –
UBS Group
16
UBS Group
Switzerland
$11K – – –
Royal Bank of Canada
17
Royal Bank of Canada
Ontario, Canada
$7K – – –
Bank of America
18
Bank of America
North Carolina
$4K – – –
TRCT
19
Tower Research Capital (TRC)
New York
$4K – – –
Creative Planning
20
Creative Planning
Kansas
$2K – – –
Manulife (Manufacturers Life Insurance)
21
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1K – – –
NC
22
NewSquare Capital
Pennsylvania
$1K – – –
OIA
23
OneDigital Investment Advisors
Kansas
$1K – – –
SPIA
24
Steward Partners Investment Advisory
New York
$1K – – –
SM
25
Sabby Management
Florida
– -$2.63M -6 Closed
1
2

PALI Hedge Fund Activity: Q2 2017 in Review

5 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Palisade Bio (PALI) for Q2 2017, worth a combined $5.14M — down 35% from $7.85M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of PALI and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was William Blair & Company, opening a new position worth an estimated $439K. The largest seller was Sabby Management, exiting entirely with an estimated $2.63M sold.

  • 5 institutional investors held Palisade Bio (PALI) as of Q2 2017, down from 7 in Q1 2017.
  • Funds reported $5.14M of Palisade Bio stock for Q2 2017, down 35% quarter-over-quarter.
  • 1 fund opened new Palisade Bio positions in Q2 2017 and 3 closed out, a net change of -2 holders.
  • The largest Palisade Bio buyer in Q2 2017 was William Blair & Company, an estimated $439K added.
  • The largest Palisade Bio seller in Q2 2017 was Sabby Management, an estimated $2.63M sold.

Based on aggregated 13F filings for Q2 2017.